NAVIDEA BIOPHARMACEUTICALS, INC. Notes Payable
NAVIDEA BIOPHARMACEUTICALS, INC. had Notes Payable of $2.10 million as of 2017-03-31, per its 10-Q filed 2017-05-10.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes and Loans Payable › Notes Payable
us-gaap:NotesPayable · last filed 2017-05-10
- 2017-03-31: Notes Payable $2.10M.
- 2016-09-30: Notes Payable $62.20M.
- 2016-06-30: Notes Payable $61.20M.
- 2016-03-31: Notes Payable $60.90M.
| Period end | Notes Payable |
|---|---|
| 2017-03-31 | $2.10M 10-Q · filed 2017-05-10 |
| 2016-09-30 | $62.20M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $61.20M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $60.90M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $61.10M 10-K · filed 2016-03-23 |
| 2015-09-30 | $61.30M 10-Q · filed 2015-11-09 |
| 2014-12-31 | $33.80M 10-K · filed 2016-03-23 |